InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Q32 Bio Inc.

FIXX Clue Score74
United States Fiscal year ends December CIK 0001661998 Results filed 4 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

137
Insider
Date
Role
Action
Shares
Price
Amount
Lee Kalowski
6 Oct 2026
CFO and President
Sell
1,301
$8.32
$10.82K
Shelia M. Violette
6 Oct 2026
Chief Scientific Officer
Sell
917
$8.32
$7.63K
Jodie Pope Morrison
6 Oct 2026
CEO
Sell
3,221
$8.32
$26.80K
Shelia M. Violette
25 Aug 2026
Chief Scientific Officer
Sell
2,798
$16.56
$46.33K
Lee Kalowski
25 Aug 2026
CFO and President
Sell
3,972
$16.56
$65.78K
Jodie Pope Morrison
25 Aug 2026
CEO
Sell
9,845
$16.56
$163.03K
Isaac Manke
30 Jun 2026
Director
Exercised, kept
53,521
$2.80
$149.86K
Orbimed Advisors LLC
28 May 2026
Director
Buy indirect
625,000
$8.00
$5.00M
Orbimed Advisors LLC
28 May 2026
Director
Buy indirect
1,250,000
$8.00
$10.00M
Diyong Xu
28 May 2026
Director
Buy indirect
625,000
$8.00
$5.00M
Diyong Xu
28 May 2026
Director
Buy indirect
1,250,000
$8.00
$10.00M
Shelia M. Violette
25 Feb 2026
Chief Scientific Officer
Sell
2,815
$4.51
$12.71K
Jodie Pope Morrison
25 Feb 2026
CEO
Sell
9,896
$4.51
$44.67K
Lee Kalowski
25 Feb 2026
CFO and President
Sell
3,995
$4.51
$18.04K
Lee Kalowski
2 Dec 2025
CFO and President
Sell
9,072
$3.46
$31.40K
Jodie Pope Morrison
2 Dec 2025
CEO
Sell
22,506
$3.46
$77.87K
Lee Kalowski
26 Aug 2025
CFO and President
Sell
4,240
$1.80
$7.64K
Shelia M. Violette
26 Aug 2025
Chief Scientific Officer
Sell
2,990
$1.80
$5.38K
Jodie Pope Morrison
26 Aug 2025
CEO
Sell
10,494
$1.80
$18.90K
Shelia M. Violette
15 Oct 2024
Chief Scientific Officer
Exercised, kept
6,000
$7.29
$43.74K
Shelia M. Violette
11 Oct 2024
Chief Scientific Officer
Exercised, kept
4,574
$3.12
$14.27K
Shelia M. Violette
8 Oct 2024
Chief Scientific Officer
Exercised, kept
13,300
$3.12
$41.50K
Charles Michaud Jr
25 Mar 2024
See Remarks
Sell
75
$24.20
$1.82K
Paul Alloway
25 Mar 2024
See Remarks
Sell
268
$24.21
$6.49K
Arthur Tzianabos
25 Mar 2024
Director
Sold after exercise
265
$24.20
$6.41K
Arthur Tzianabos
9 Jan 2024
Director
Sold on a plan
13,037
$0.57
$7.45K
Charles Michaud Jr
3 Jan 2024
See Remarks
Sell
1,708
$0.57
$975.27
Paul Alloway
3 Jan 2024
See Remarks
Sell
7,280
$0.57
$4.12K
Albert Seymour
6 Sep 2023
See Remarks
Sold after exercise
1,448
$1.15
$1.67K
Julie Jordan
3 Aug 2023
Chief Medical Officer
Sold after exercise
1,308
$1.39
$1.82K
Julie Jordan
3 Aug 2023
Chief Medical Officer
Sold after exercise
109
$1.39
$151.51
Julie Jordan
3 Aug 2023
Chief Medical Officer
Sold after exercise
436
$1.39
$606.04
Julie Jordan
2 Aug 2023
Chief Medical Officer
Sold after exercise
99
$1.31
$129.69
Paul Alloway
2 Mar 2023
See Remarks
Sell
10,965
$1.45
$15.86K
Arthur Tzianabos
9 Jan 2023
Director
Sell
10,616
$1.39
$14.76K
Albert Seymour
9 Jan 2023
See Remarks
Sell
3,620
$1.39
$5.03K
W Bradford Smith
9 Jan 2023
See Remarks
Sell
3,729
$1.39
$5.19K
Paul Alloway
9 Jan 2023
See Remarks
Sell
3,090
$1.39
$4.30K
Michael Lee Blum
9 Jan 2023
Chief Commercial Officer
Sell
2,454
$1.39
$3.41K
Arthur Tzianabos
5 Jan 2022
President & CEO
Sell
5,354
$3.78
$20.24K
Gabriel Cohn
5 Jan 2022
Chief Medical Officer
Sell
1,661
$3.78
$6.28K
Albert Seymour
5 Jan 2022
Chief Scientific Officer
Sell
1,661
$3.78
$6.28K
Timothy P Kelly
5 Jan 2022
Chief Operating Officer
Sell
1,406
$3.78
$5.31K
W Bradford Smith
5 Jan 2022
CFO & Treasurer
Sell
2,182
$3.78
$8.25K
Timothy P Kelly
3 Sep 2021
See Remarks.
Sell
54
$7.70
$415.80
Timothy P Kelly
1 Mar 2021
See Remarks.
Sold after exercise
6,232
$11.16
$69.56K
W Bradford Smith
8 Feb 2021
CFO & Treasurer
Sold after exercise
13,500
$14.25
$192.42K
Timothy P Kelly
2 Feb 2021
See Remarks
Sold after exercise
500
$13.00
$6.50K
Timothy P Kelly
1 Feb 2021
See Remarks
Sold after exercise
4,000
$12.37
$49.46K
Timothy P Kelly
12 Jan 2021
See Remarks
Sold after exercise
500
$13.00
$6.50K
Albert Seymour
7 Jan 2021
Chief Scientific Officer
Sell
5,103
$12.05
$61.47K
Albert Seymour
6 Jan 2021
Chief Scientific Officer
Sell
9,897
$12.06
$119.40K
Albert Seymour
5 Jan 2021
Chief Scientific Officer
Sell
10,000
$11.44
$114.42K
Timothy P Kelly
4 Jan 2021
See Remarks
Sold after exercise
4,000
$11.50
$45.98K
5AM Ventures IV, L.P.
22 Dec 2020
10% owner
Sell indirect
20,000
$12.82
$256.40K
5AM Ventures IV, L.P.
22 Dec 2020
10% owner
Sell indirect
480,000
$12.82
$6.15M
Kush Parmar
22 Dec 2020
Director
Sell indirect
20,000
$12.82
$256.40K
Kush Parmar
22 Dec 2020
Director
Sell indirect
480,000
$12.82
$6.15M
5AM Ventures IV, L.P.
14 Dec 2020
10% owner
Sell indirect
13,703
$11.88
$162.79K
5AM Ventures IV, L.P.
14 Dec 2020
10% owner
Sell indirect
6,297
$13.06
$82.24K
5AM Ventures IV, L.P.
14 Dec 2020
10% owner
Sell indirect
328,862
$11.88
$3.91M
5AM Ventures IV, L.P.
14 Dec 2020
10% owner
Sell indirect
151,138
$13.06
$1.97M
Kush Parmar
14 Dec 2020
Director
Sell indirect
13,703
$11.88
$162.79K
Kush Parmar
14 Dec 2020
Director
Sell indirect
6,297
$13.06
$82.24K
Kush Parmar
14 Dec 2020
Director
Sell indirect
328,862
$11.88
$3.91M
Kush Parmar
14 Dec 2020
Director
Sell indirect
151,138
$13.06
$1.97M
Timothy P Kelly
17 Mar 2020
See Remarks
Sell
1,315
$13.01
$17.11K
Arthur Tzianabos
3 Feb 2020
President & CEO
Sell
12,500
$16.16
$202.02K
W Bradford Smith
3 Feb 2020
CFO, Treasurer & Secretary
Sold after exercise
12,000
$16.16
$193.87K
James E Flynn
30 Jan 2020
10% owner
Sell indirect
509,970
$15.45
$7.88M
James E Flynn
29 Jan 2020
10% owner
Sell indirect
8,857
$15.45
$136.81K
James E Flynn
28 Jan 2020
10% owner
Sell indirect
65,891
$15.51
$1.02M
James E Flynn
27 Jan 2020
10% owner
Sell indirect
193,359
$15.77
$3.05M
James E Flynn
24 Jan 2020
10% owner
Sell indirect
380,256
$15.69
$5.96M
W Bradford Smith
2 Jan 2020
CFO, Treasurer & Secretary
Sold after exercise
6,000
$20.50
$122.98K
Albert Seymour
2 Jan 2020
Chief Scientific Officer
Sell
9,133
$20.50
$187.22K
Arthur Tzianabos
2 Jan 2020
President & CEO
Sell
12,500
$20.50
$256.19K
James E Flynn
24 Dec 2019
10% owner
Sell indirect
151,233
$21.95
$3.32M
James E Flynn
24 Dec 2019
10% owner
Sell indirect
198,767
$21.95
$4.36M
James E Flynn
23 Dec 2019
10% owner
Sell indirect
56,595
$21.83
$1.24M
James E Flynn
23 Dec 2019
10% owner
Sell indirect
74,384
$21.83
$1.62M
James E Flynn
20 Dec 2019
10% owner
Sell indirect
9,130
$21.50
$196.30K
James E Flynn
20 Dec 2019
10% owner
Sell indirect
11,999
$21.50
$257.98K
James E Flynn
19 Dec 2019
10% owner
Sell indirect
5,454
$21.68
$118.22K
James E Flynn
19 Dec 2019
10% owner
Sell indirect
7,168
$21.68
$155.37K
Albert Seymour
2 Dec 2019
Chief Scientific Officer
Sell
9,300
$16.23
$150.97K
Arthur Tzianabos
2 Dec 2019
President & CEO
Sell
12,500
$16.25
$203.18K
W Bradford Smith
2 Dec 2019
CFO, Treasurer & Secretary
Sold after exercise
6,000
$16.21
$97.27K
Albert Seymour
29 Nov 2019
Chief Scientific Officer
Sell
9,300
$16.06
$149.39K
Arthur Tzianabos
29 Nov 2019
President & CEO
Sell
12,500
$16.04
$200.56K
W Bradford Smith
29 Nov 2019
CFO, Treasurer & Secretary
Sold after exercise
6,000
$16.00
$96.00K
Richard J. Gregory
18 Nov 2019
Director
Exercised, kept
10,806
$0.03
$324.18
Albert Seymour
1 Oct 2019
Chief Scientific Officer
Sell
100
$18.23
$1.82K
Albert Seymour
1 Oct 2019
Chief Scientific Officer
Sell
9,200
$17.38
$159.94K
Arthur Tzianabos
1 Oct 2019
President & CEO
Sell
100
$18.23
$1.82K
Arthur Tzianabos
1 Oct 2019
President & CEO
Sell
12,400
$17.39
$215.64K
W Bradford Smith
1 Oct 2019
CFO, Treasurer & Secretary
Sold after exercise
100
$18.23
$1.82K
W Bradford Smith
1 Oct 2019
CFO, Treasurer & Secretary
Sold after exercise
5,900
$17.38
$102.54K
Timothy P Kelly
5 Sep 2019
See Remarks
Sell
1,166
$19.94
$23.25K
Arthur Tzianabos
3 Sep 2019
President & CEO
Sell
12,500
$18.75
$234.32K
Albert Seymour
3 Sep 2019
Chief Scientific Officer
Sell
9,300
$18.74
$174.28K
W Bradford Smith
3 Sep 2019
CFO, Treasurer & Secretary
Sold after exercise
6,000
$18.74
$112.42K
Arthur Tzianabos
1 Aug 2019
President & CEO
Sell
12,500
$17.37
$217.11K
W Bradford Smith
1 Aug 2019
CFO, Treasurer & Secretary
Sold after exercise
6,000
$17.37
$104.19K
Albert Seymour
1 Aug 2019
Chief Scientific Officer
Sell
9,300
$17.37
$161.52K
Siyamak Rasty
9 Jul 2019
Chief Operating Officer
Sell
8,000
$20.00
$160.00K
Arthur Tzianabos
1 Jul 2019
President & CEO
Sell
12,500
$18.98
$237.30K
W Bradford Smith
1 Jul 2019
CFO, Treasurer & Secretary
Sold after exercise
6,000
$19.00
$113.97K
Albert Seymour
1 Jul 2019
Chief Scientific Officer
Sell
100
$19.56
$1.96K
Albert Seymour
1 Jul 2019
Chief Scientific Officer
Sell
9,200
$18.98
$174.58K
Siyamak Rasty
3 Jun 2019
Chief Operating Officer
Sell
8,000
$20.22
$161.78K
Arthur Tzianabos
3 Jun 2019
President & CEO
Sell
12,500
$19.86
$248.26K
Albert Seymour
3 Jun 2019
Chief Scientific Officer
Sell
9,300
$19.90
$185.09K
Timothy P Kelly
3 Jun 2019
See Remarks
Sell
1,288
$20.00
$25.76K
W Bradford Smith
3 Jun 2019
CFO, Treasurer & Secretary
Sold after exercise
6,000
$19.94
$119.66K
Kush Parmar
16 May 2019
Director
Sell indirect
24,600
$21.47
$528.16K
Kush Parmar
16 May 2019
Director
Sell indirect
590,400
$21.47
$12.68M
5AM Ventures IV, L.P.
16 May 2019
10% owner
Sell indirect
24,600
$21.47
$528.16K
5AM Ventures IV, L.P.
16 May 2019
10% owner
Sell indirect
590,400
$21.47
$12.68M
James E Flynn
12 Apr 2019
Director
Buy indirect
533,333
$22.50
$12.00M
Kush Parmar
10 Dec 2018
Director
Sell indirect
623
$26.01
$16.20K
Kush Parmar
10 Dec 2018
Director
Sell indirect
14,952
$26.01
$388.83K
5AM Ventures IV, L.P.
10 Dec 2018
10% owner
Sell indirect
623
$26.01
$16.20K
5AM Ventures IV, L.P.
10 Dec 2018
10% owner
Sell indirect
14,952
$26.01
$388.83K
5AM Ventures IV, L.P.
23 Nov 2018
10% owner
Sell indirect
1,187
$20.04
$23.78K
5AM Ventures IV, L.P.
23 Nov 2018
10% owner
Sell indirect
28,495
$20.04
$570.93K
Kush Parmar
23 Nov 2018
Director
Sell indirect
1,187
$20.04
$23.78K
Kush Parmar
23 Nov 2018
Director
Sell indirect
28,495
$20.04
$570.93K
5AM Ventures IV, L.P.
16 Nov 2018
10% owner
Sell indirect
21,036
$20.20
$424.93K
5AM Ventures IV, L.P.
16 Nov 2018
10% owner
Sell indirect
504,864
$20.20
$10.20M
Kush Parmar
16 Nov 2018
Director
Sell indirect
21,036
$20.20
$424.93K
Kush Parmar
16 Nov 2018
Director
Sell indirect
504,864
$20.20
$10.20M
Temasek Holdings (Private) Ltd
2 Apr 2018
10% owner
Buy indirect
625,000
$16.00
$10.00M
Vida Ventures, LLC
2 Apr 2018
10% owner
Buy indirect
375,000
$16.00
$6.00M
Rock Springs Capital Management LP
2 Apr 2018
10% owner
Buy indirect
250,000
$16.00
$4.00M
James E Flynn
2 Apr 2018
Director
Buy indirect
625,000
$16.00
$10.00M
James E Flynn
2 Apr 2018
Director
Buy indirect
625,000
$16.00
$10.00M

What was left out

Form 4 filings counted 238
Amendments (4/A) skipped 15
Filings about a different issuer 0
Unreadable filings 0
Joint filings 22
Sales on a Rule 10b5-1 plan 1
Sales straight out of an exercise 22
Sales at will 99
Transactions with no price 0
Shares from compensation/vesting 34,811,374
Sales filed before the plan box existed 81
History held since 29 Mar 2018